Bank of Montreal’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.99M Buy
71,000
+54,000
+318% +$1.44M ﹤0.01% 1671
2025
Q4
$423K Sell
17,000
-168,300
-91% -$4.24M ﹤0.01% 2392
2025
Q3
$4.72M Buy
+185,300
New +$4.57M ﹤0.01% 1314
2024
Q4
Sell
-30,500
Closed -$887K 3853
2024
Q3
$887K Hold
30,500
﹤0.01% 2102
2024
Q2
$861K Hold
30,500
﹤0.01% 2112
2024
Q1
$848K Sell
30,500
-30,000
-50% -$832K ﹤0.01% 2098
2023
Q4
$1.8M Sell
60,500
-220,000
-78% -$6.65M ﹤0.01% 1742
2023
Q3
$10.4M Hold
280,500
﹤0.01% 977
2023
Q2
$11.3M Hold
280,500
﹤0.01% 972
2023
Q1
$13.8M Buy
+280,500
New +$12.1M 0.01% 806
2022
Q3
Sell
-200
Closed -$10 4344
2022
Q2
$10 Sell
200
-249,800
-100% -$12.7M ﹤0.01% 3855
2022
Q1
$13.3M Buy
+250,000
New +$13M 0.01% 1012
2021
Q4
Sell
-400,500
Closed -$17.6M 3769
2021
Q3
$17.6M Buy
+400,500
New +$17.7M 0.01% 1008
2021
Q1
Sell
-5,900
Closed -$223K 5286
2020
Q4
$223K Sell
5,900
-319
-5% -$11.7K ﹤0.01% 3168
2020
Q3
$213K Buy
+6,219
New +$218K ﹤0.01% 2720
2019
Q3
Sell
-22,134
Closed -$910K 4928
2019
Q2
$910K Buy
+22,134
New +$879K ﹤0.01% 2115
2017
Q2
Sell
-6,535
Closed -$212K 4252
2017
Q1
$212K Buy
+6,535
New +$206K ﹤0.01% 2435
2014
Q2
Sell
-15,810
Closed -$482K 4778
2014
Q1
$482K Buy
+15,810
New +$471K ﹤0.01% 2068

Other funds holding PFE

Bank of Montreal's PFE Position: Q1 2026 in Review

Bank of Montreal reduced its Pfizer (PFE) stake by 20% in Q1 2026, selling an estimated $52.6M and leaving 7,667,405 shares worth $215M. The position accounts for 0.08% of the portfolio, ranked #199.

Bank of Montreal first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $971M in Q3 2018. 2,941 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bank of Montreal held 7,667,405 shares of Pfizer worth $215M as of Q1 2026.
  • Bank of Montreal sold 1,975,174 Pfizer shares in Q1 2026, an estimated $52.6M.
  • Pfizer made up 0.08% of Bank of Montreal's portfolio in Q1 2026, its #199 holding.
  • Bank of Montreal first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Pfizer position peaked at $971M in Q3 2018.
  • 2,941 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.